Polysaccharide peptide (PsP) Ganoderma lucidum: a potential inducer for vascular repair in type 2 diabetes mellitus model

References

• Mozaffarian D, Bejamin EJ, Go AS, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics–2016 update: a report from the American Heart Association. Circulation. 2016;133:447–454.
   Google Scholar
• World Health Organization Geneva. (2017). Fact sheet on Diabetes. [Updated 7, 2017]. Available from: http://www.who.int/mediacentre/factsheets/fs312/en/. Accessed 805, 2017
   Google Scholar
• Dasar RK. Badan Penelitian Dan Pengembangan Kesehatan. Jakarta: Kementerian Kesehatan Republik Indonesia; 2013:85–90.
   Google Scholar
• Santos ADL, Cecílio HPM, Teston EF, Arruda GOD, Peternella FMN, Marcon SS. Microvascular complications in type 2 diabetes and associated factors: a telephone survey of self-reported morbidity. Cien Saude Colet. 2015;20(3):761–770. doi:10.1590/1413-81232015203.1218201425760116
   PubMed Web of Science ®Google Scholar
• Ulutas KT, Dokuyucu R, Sefil F, et al. Evaluation of mean platelet volume in patients with type 2 diabetes mellitus and blood glucose regulation: a marker for atherosclerosis? Int J Clin Exp Med. 2014;7(4):955–961.24955167
   PubMed Web of Science ®Google Scholar
• Sena CM, Pereira AM, Seiça R. Endothelial dysfunction - a major mediator of diabetic vascular disease.Biochim Biophys Acta. 2013;1832:2216–2231. doi:10.1016/j.bbadis.2013.08.00623994612
   PubMed Web of Science ®Google Scholar
• Lassegue B, Griendling KK. NADPH oxidases: functions and pathologies in the vasculature, Arterioscler. Thromb Vasc Biol. 2010;30:653–661. doi:10.1161/ATVBAHA.108.181610
   PubMed Web of Science ®Google Scholar
• Jezek P, Hlavata L. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism, Int. J Biochem Cell Biol. 2005;37:2478–2503. doi:10.1016/j.biocel.2005.05.013
   PubMed Web of Science ®Google Scholar
• Turrens JF. Mitochondrial formation of reactive oxygen species, J. Physiol. 2003;552:335–344. doi:10.1113/jphysiol.2003.049478
   Web of Science ®Google Scholar
• Chung HY, Baek BS, Song SH, et al. Xanthine dehydrogenase/xanthine oxidase and oxidative stress. Age. 1997;20(3):127–140. doi:10.1007/s11357-997-0012-223604305
   PubMedGoogle Scholar
• J-M L, Lin PH, Yao Q, Chen C. Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems. J Cell Mol Med. 2010;14(4):840–860. doi:10.1111/j.1582-4934.2009.0089719754673
   PubMed Web of Science ®Google Scholar
• Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87:840–844. doi:10.1161/01.res.87.6.48011073878
   PubMed Web of Science ®Google Scholar
• Brownlee M. The pathobiology of diabetes complications: a unifying mechanism. Diabetes. 2005;54:1615–1625. doi:10.2337/diabetes.54.6.161515919781
   PubMed Web of Science ®Google Scholar
• Wihastuti TA, Sargowo D, Tjokroprawiro A, Permatasari N, Widodo MA, Soeharto S. Vasa Vasorum Anti-angiogenesis through H2O2, HIF-1α, NF-kB, and iNOS inhibition by mango-steen pericarp ethanolic extract (Garcinia mangostana Linn) inhipercholesterol diet given Rattus novergicus Wistar strain. Vasc Health Risk Manag. 2014;10:523–531. doi:10.2147/VHRM.S6173625187725
   PubMedGoogle Scholar
• Boamponsem AK, Boamponsem LK. The role of inflammation in atherosclerosis. Pelagia Res Lib. 2011;2(4):194−207.
   Google Scholar
• Sabatier F, Camoin-Jau L, Anfosso F, Sampol J, Dignat-George F. Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence. J Cell Mol Med. 2009;13(3):454–457. doi:10.1111/j.1582-4934.2008.00639.x19379144
   PubMed Web of Science ®Google Scholar
• Du F, Zhou J, Gong R, et al. Endothelial progenitor cells in atherosclerosis. Front Biosci. 2012;17:2327–2349. doi:10.2741/4055
   PubMed Web of Science ®Google Scholar
• Liu P, Zhou B, Gu D, Zhang L, Han Z. Endothelial progenitor cell therapy in atherosclerosis: A double-edged sword? Ageing Res Rev. 2009;8;pp:83–93. doi:10.1016/0006-2952(75)90029-5
   Web of Science ®Google Scholar
• Pompilio G, Capogrossi MC, Pesce M, et al. Review: endothelial progenitor cells and cardiovascular homeostasis: clinical implications. Int J Cardiol. 2009;131:156–167. doi:10.1016/j.ijcard.2008.11.04818823669
   PubMed Web of Science ®Google Scholar
• Schmidt-Lucke C, Fichtlscherer S, Aicher A, et al. Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol. PLoS One. 2010;5(11):e13790. doi:10.1371/journal.pone.001379021072182
   PubMed Web of Science ®Google Scholar
• Xu Z, Chen X, Zhong Z, et al. Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities. Am J Chin Med. 2011;39:15–27. doi:10.1142/S0192415X1100861021213395
   PubMed Web of Science ®Google Scholar
• Wihastuti TA, Heriansyah T. The inhibitory effects of polysaccharide peptides (PsP) of Ganoderma lucidum against atherosclerosis in rats with dyslipidemia. Heart Int. 2017;12(1):e1–e7.
   Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Suppl. 1):81–90. doi:10.2337/dc14-S08123959568
   PubMed Web of Science ®Google Scholar
• Baynes HW. Classification, pathophysiology, diagnosis and management of diabetes mellitus. J Diabetes Metab. 2015;6:541. doi:10.4172/2155-6156.1000541
   Web of Science ®Google Scholar
• Perkumpulan Endokrinologi Indonesia. Konsensus Pengendalian Dan Pencegahan Diabetes Mellitus Tipe 2 Di Indonesia. Jakarta: PB. PERKENI; 2015:11–14.
   Google Scholar
• Teramoto T, Sasaki J, Ishibashi S, et al. Diagnostic criteria for dyslipidemia executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases. 2012 Japan version. Journal of Atherosclerosis and Thrombosis, 20(8), 655-660.  https://doi.org/10.5551/jat.17152.
   Google Scholar
• Seto SW, Lam TY, Tam HL, et al. Novel hypoglycemic effects of Ganoderma lucidum water-extract in obese/diabetic (+db/+db) mice. Phytomedicine. 2009;16(5):426–436. doi:10.1016/j.phymed.2008.10.00419109000
   PubMed Web of Science ®Google Scholar
• Gleissner CA, Galkina E, Nadler JL, Ley K. Mechanisms by which diabetes increases cardiovascular disease. Drug Discov Today Dis Mech. 2007;4(3):131–140. doi:10.1016/j.ddmec.2007.12.00518695749
   PubMedGoogle Scholar
• Benzie IFF, Wachtel-Galor S. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd ed. Boca Raton (FL): CRC Press/Taylor & Francis;Available from; 2011 Available from: https://www.ncbi.nlm.nih.gov/books/NBK92771. Accessed 909, 2019.
   Google Scholar
• Ferraro F, Lymperi S, Méndez-Ferrer S, et al. Diabetes impairs hematopoietic stem cell mobilization through alteration of niche function. Sci Transl Med. 2011;3(104):104ra101. doi:10.1126/scitranslmed.3002191
   PubMed Web of Science ®Google Scholar
• Kumar A; Fausto. Pathologic Basis of Disease. 7th ed. Elsvier-Saunders: New York; 2005.
   Google Scholar
• Lampka M, Grąbczewska Z, Jendryczka-Maćkiewicz E, et al. Circulating endothelial cells in coronary artery disease. Kardiol Pol. 2010;68(10):1100–1105.20967702
   PubMed Web of Science ®Google Scholar
• Liu P, Zhou B, Gu D, Zhang L, Han Z. Endothelial progenitor cell therapy in atherosclerosis : a double-edged sword? Ageing Res Rev. 2009;8:83–93. doi:10.1016/j.arr.2008.11.00219103308
   PubMed Web of Science ®Google Scholar
• Hristov M, Erl W, Weber PC. Endothelial Progenitor Cell. Arterioscler Thromb Vasc Biol. 2003;23:1185–1189. doi:10.1161/01.ATV.0000073832.49290.B512714439
   PubMed Web of Science ®Google Scholar
• Yu C-G, Zhang N, Yuan -S-S, et al. Endothelial progenitor cells in diabetic microvascular complications: friends or foes? Stem Cells Int. 2016;1803989. doi:10.1155/2016/180398927313624
   PubMed Web of Science ®Google Scholar
• Hamed S. Endothelial Progenitor Cell Dysfunction in Diabetes Mellitus Type-2: Focus on Nitric Oxide System, Medical Complications of Type 2 Diabetes, Dr. Colleen Croniger (Ed.), ISBN: 978-953-307-363-7, InTech. 2010 Available from: http://www.intechopen.com/books/medical-complications-of-type-2-diabetes/endothelial-progenitor-cell-dysfunction-in-diabetes-mellitus-type-2-focus-on-nitric-oxide-system
   Google Scholar
• Lombardo MF, Iacopino P, Cuzzola M, et al. Type 2 diabetes mellitus impairs the maturation of endothelial progenitor cells and increases the number of circulating endothelial cells in peripheral blood. Cytometry. 2012;81A:856–864. doi:10.1002/cyto.a.22109
   Google Scholar
• Nelwan EJ, Widjajanto E, Andarini S, Djati MS. Modified risk factors for Coronary Heart Disease In Minahasa Ethnic Group, Manado. J Exp Life Sci. 2016;6(2):88–94. doi:10.21776/ub.jels.2016.006.02.06
   Google Scholar
• Gallagher KA, Liu ZJ, Xiao M, et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1α. J Clin Invest. 2007;117:1249–1259. doi:10.1172/JCI2971017476357
   PubMed Web of Science ®Google Scholar
• Ceradini DJ, Yao D, Grogan RH, et al. Decreasing intracellular superoxide corrects defective ischemia-induced new vessel formation in diabetic mice. J Biol Chem. 2008;283:10930–10938. doi:10.1074/jbc.M70745120018227068
   PubMed Web of Science ®Google Scholar
• CUBBON RM, Kahn MB, Wheatcroft SB. Effects of insulin resistance on endothelial progenitor cells and vascular repair. Clin Sci. 2009;117:173–190. doi:10.1042/CS20080263; Printed in Great Britain.19630751
   PubMed Web of Science ®Google Scholar
• Zhou B, Andriana Margariti L, Margariti A, Zeng L, Xu Q. Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis. Cardiovasc Res. 2011;90:413–420. doi:10.1093/cvr/cvr00321233251
   PubMed Web of Science ®Google Scholar
• BAZZONI GIANFRANCO, DEJANA ELISABETTA. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev. 2004;84:869–901. doi:10.1152/physrev.00035.200315269339
   PubMed Web of Science ®Google Scholar
• Berezin AE. Endothelial progenitor cells dysfunction in diabetes mellitus. ARC J Diabetes Endocrinol. 2016;2(1):29–37. doi:10.20431/2455-5983.0201005.
   Google Scholar
• Dhananjayan R, Srivani Koundinya KS. Endothelial Dysfunction in Type 2 Diabetes Mellitus. Ind J Clin Biochem. 2016;31(4):372–379. doi:10.1007/s12291-015-0516-y
   PubMed Web of Science ®Google Scholar
• Desouza CV, Frederick G, Hamel FG, Bidasee K, O’Connell K. Role of inflammation and insulin resistance in endothelial progenitor cell dysfunction. DIABETES. 2011;60.doi:10.2337/db10-0875.
   Web of Science ®Google Scholar
• Huizer K, Mustafa DAM, Mustafa DA, Spelt JC, et al. Improving the characterization of endothelial progenitor cell subsets by an optimized FACS protocol. PLoS One. 2017;12(9):e0184895. doi:10.1371/journal.pone.018489528910385
   PubMed Web of Science ®Google Scholar